Volume 2.28 | Jul 20

Mesenchymal Cell News 2.28, July 20, 2010.
In this issue: Science News  |  Current Publications  |  Industry News  |  Policy News  |  Events Subscribe  |  Unsubscribe

TOP STORY

Scientists Develop New Way to Grow Adult Stem Cells in Culture   
Researchers at Stanford University have found that growing muscle stem cells on a specially developed synthetic matrix that mimics the elasticity of real muscles allows them to maintain their self-renewing properties.  [Press release from Stanford University School of Medicine discussing online prepublication in Science]

TeSR™2  

Animal Protein-Free
Feeder-Independent Maintenance Medium for hESCs & hiPSCs

by STEMCELL Technologies
 
 
WATCH THE TeSR2 VIDEO STEMCELL Technologies Inc


 


SCIENCE NEWS

A New Generation of Biological Scaffolds
Researchers have been working on ways of producing biological scaffolds, derived from natural human or animal tissues that will not be rejected by a patient’s immune system and can be repaired and renewed like normal tissue. [Press release from the University of Leeds discussing research presented at the UK National Stem Cell Network Annual Meeting]

MesenCult®-XF Medium  

Obtain more MSCs in fewer passages with
MesenCult®-XF Medium

by STEMCELL Technologies
 
 
WATCH THE VIDEO STEMCELL Technologies Inc


 



CURRENT PUBLICATIONS (Ranked by Impact Factor of the Journal)

Substrate Elasticity Regulates Skeletal Muscle Stem Cell Self-Renewal in Culture
Using a bioengineered substrate to recapitulate key biophysical and biochemical niche features in conjunction with a novel highly automated single cell tracking algorithm, scientists show that substrate elasticity is a potent regulator of MuSC fate in culture. [Science]

Unique Precursors for the Mesenchymal Cells Involved in Injury Response and Fibrosis
Researchers investigated an alternative pathway for emergence of the mesenchymal cells involved in epithelial sheet wound healing and a source of myofibroblasts that cause fibrosis. [Proc Natl Acad Sci USA]

The Mood Stabilizers Valproic Acid and Lithium Enhance Mesenchymal Stem Cell Migration via Distinct Mechanisms
This study investigated whether treatment of mesenchymal stem cells with two mood stabilizers, valproic acid and lithium, would enhance cell migration and, if so, explored the mechanisms underlying their effects. [Neuropsychopharmacology]

Endothelial Progenitor Cells Undergo an Endothelial to Mesenchymal Transition-Like Process Mediated by TGFBetaRI
Study’s results indicate that endothelial progenitor cells (EPC) may differentiate into smooth muscle cell-like cells through an endothelial-to-mesenchymal transition-like process and that transforming growth factor beta1 (TGFBeta1) plays an important role in the fate of EPC. [Cardiovasc Res]

TGFBeta/BMP Type I Receptors ALK1 and ALK2 are Essential for BMP9-Induced Osteogenic Signaling in Mesenchymal Stem Cells
Using dominant-negative mutants for the seven type I receptors, researchers demonstrated that only ALK1 and ALK2 mutants effectively inhibit bone morphogenetic protein (BMP)9-induced osteogenic differentiation in vitro and ectopic ossification in mesenchymal stem cell implantation assays. [J Biol Chem]

Polyethylenimine-Mediated Gene Delivery into Human Bone Marrow Mesenchymal Stem Cells from Patients
This study was designed to improve the understanding of genetic modification of human bone marrow derived mesenchymal stem cells by polyethylenimine, a  non-viral vector that shows promise in stem cell genetic modification, in the context of cardiac regeneration for patients. [J Cell Mol Med]

Stromal Cells’ B7-1 is a Key Stimulatory Molecule for Interleukin-10 Production by HOZOT, a Multifunctional Regulatory T Cell Line
Investigators demonstrated that B7-1 on stromal cells is a key molecule regulating IL-10 production by multifunctional regulatory T cells, HOZOT. [Immunol Cell Biol]

Obstructive Apneas Induce Early Activation of Mesenchymal Stem Cells and Enhancement of Endothelial Wound Healing
Investigators tested the hypothesis that the blood serum of rats subjected to recurrent airway obstructions mimicking obstructive sleep apnea induces early activation of bone marrow-derived mesenchymal stem cells and enhancement of endothelial wound healing. [Respir Res]

A Novel Vascularized Patch Enhances Cell Survival and Modifies Ventricular Remodeling in a Rat Myocardial Infarction Model
The omentum-based cell-supporting patch provided a favorable microenvironment for transplanted mesenchymal stem cell survival, which resulted in favorable ventricular remodeling and restoration of cardiac functions in rats with experimental myocardial infarction. [J Thorac Cardiovasc Surg]

INDUSTRY NEWS

Phase III Meeting Scheduled with FDA Following Results of Bone Marrow Regeneration Trial
Australian regenerative medicine company, Mesoblast Limited, announced that based on positive results from its bone marrow transplant clinical trial, a formal meeting has been scheduled with the United States Food and Drug Administration to discuss a proposed Phase III clinical trial program. [Mesoblast Limited Press Release]

Kiadis Pharma Receives IND Approval from FDA to Start Pivotal Clinical Trial with ATIR™
Biopharmaceutical Company Kiadis Pharma announced that it has received approval for its Investigational New Drug application with the US Food and Drug Administration to start the pivotal clinical study for its product ATIR™ in the United States. [Kiadis Pharma Press Release]

NIH Awards Rice $1.7 Million for Cartilage-Regeneration Research
Bioengineers from Rice University’s BioScience Research Collaborative have won a $1.7 million grant from the National Institutes of Health to develop an injectable mix of polymers and adult stem cells that can spur the growth of new cartilage in injured knees and other joints. [EurekAlert! Press Release]

John Hopkins University Hits $200 Million Mark in ARRA Grants
The John Hopkins University has to date been awarded more than $200 million in National Institutes of Health and National Science Foundation research grants through the American Recovery and Reinvestment Act (ARRA) of 2009. [The JHU Gazette] 


POLICY NEWS

Damon Runyon Cancer Research Foundation Awards Prestigious Fellowships to 18 Top Young Scientists
The Damon Runyon Cancer Research Foundation, a non-profit organization focused on supporting exceptional early career researchers and innovative cancer research, named 18 new Damon Runyon Fellows at its spring Fellowship Award Committee review. [Damon Runyon Cancer Research Foundation Press Release]

“Game Over” for British Science?
The Royal Society and the British Academy strongly warned the British government that looming cuts to science funding could be “irreversibly catastrophic for the future of U.K. science and economic growth” if they go too far. [The Royal Society and the British Academy, United Kingdom]

House Panel Approves 3.2% Raise for NIH in 2011
A House of Representatives spending panel yesterday approved a $1 billion increase, to $32 billion, in the 2011 budge for the National Institutes of Health (NIH). [National Institutes of Health, United States]

NIH Expands National Network for Transforming Clinical and Translational Research
Nine health research centers have received funds to develop ways to reduce the time it takes for clinical research to become treatments for patients. [National Institutes of Health, United States]

2011 NIH Directors New Innovator Award Program (DP2) (RFA-RM-10-009) [National Institutes of Health, United States]

NIMH Announces Availability of Funds for Competitive Revision Applications for a Repository Supporting Stem Cell Research Relevant to Mental Disorders (U24) (NOT-MH-10-024) [National Institute of Mental Health, United States]

NASA SBIR/STTR 2010 Phase I Solicitation [Small Business Innovation Research, United States]



EVENTS (Listed by Date)

2nd International Conference on Cellular and Molecular Bioengineering (ICCMB2)
August 2-4, 2010
Singapore City, Singapore

Select Biosciences 3rd Annual Stem Cells Europe Conference
August 24-25, 2010
Edinburgh, Scotland

Select Biosciences Inaugural Cellular Therapy Summit
August 24-25, 2010
Edinburgh, Scotland


United Kingdom National Stem Cell Network (UKNSCN) 3rd Annual Scientific Conference
July 12-14, 2010
Nottingham, United Kingdom

NEW International Society for Cellular Therapy (ISCT) – Europe 2nd Regional Meeting
September 11-14, 2010
Belgirate, Italy

Tissue Engineering & Regenerative Medicine International Society (TERMIS) – Asia Pacific 2010
September 15-17, 2010
Sydney, Australia

NEW 2010 World Stem Cell Summit
October 4-6, 2010
Detroit, United States

5th World Congress on Preventative and Regenerative Medicine (WCRM) 2010
October 5-7, 2010
Hannover, Germany

2010 American Society for Matrix Biology (ASMB) Meeting
October 24-27, 2010
Charleston, United States

52nd American Society of Hematology (ASH) Annual Meeting and Exposition
December 4-7, 2010
Orlando, United States

Tissue Engineering & Regenerative Medicine International Society (TERMIS) – North America 2010 Annual Conference
December 5-8, 2010
Orlando, United States

NEW
Epithelial Plasticity and Epithelial to Mesenchymal Transition (A8)
January 21-26, 2011
Vancouver, Canada

NEW
Phacilitate 7th Annual Cell & Gene Therapy Forum 2011
January 24-26, 2011
Washington DC, United States

NEW Stem Cells, Cancer and Metastasis (C4)
March 6-11, 2011
Dillon, United States

Visit our events page to stay up to date with the latest events in the cell, gene and immunotherapy community.

JOB OPPORTUNITIES


Reach more than 11,000 potential candidates by posting your organization’s career opportunities with Mesenchymal Cell News.

Visit here to post your career opportunities.



Have we missed an important article or publication in Mesenchymal Cell News? Click here to submit!



Comments or Suggestions? Email [email protected] with your feedback.



Learn more about Mesenchymal Cell News: Archives  |  Events  |  Subscribe  |  Contact Us